These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 26463956

  • 1. The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
    Decker D, Collier L, Lau T, Olivera R, Roma G, Leonardo C, Seifert H, Rowe D, Pennypacker KR.
    Acta Neurochir Suppl; 2016; 121():243-50. PubMed ID: 26463956
    [Abstract] [Full Text] [Related]

  • 2. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
    Zeynalov E, Jones SM, Seo JW, Snell LD, Elliott JP.
    PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.
    Zeynalov E, Jones SM, Elliott JP.
    PLoS One; 2017; 12(8):e0183985. PubMed ID: 28854286
    [Abstract] [Full Text] [Related]

  • 5. Hypertonic saline regulates microglial M2 polarization via miR-200b/KLF4 in cerebral edema treatment.
    Wen M, Ye J, Han Y, Huang L, Yang H, Jiang W, Chen S, Zhong W, Zeng H, Li DY.
    Biochem Biophys Res Commun; 2018 May 05; 499(2):345-353. PubMed ID: 29577903
    [Abstract] [Full Text] [Related]

  • 6. Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes.
    Zeng HK, Wang QS, Deng YY, Fang M, Chen CB, Fu YH, Jiang WQ, Jiang X.
    Neuroscience; 2010 Mar 31; 166(3):878-85. PubMed ID: 20083168
    [Abstract] [Full Text] [Related]

  • 7. Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
    Nakayama S, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A.
    Neurocrit Care; 2016 Apr 31; 24(2):273-82. PubMed ID: 26732270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline.
    Toung TJ, Chang Y, Lin J, Bhardwaj A.
    Crit Care Med; 2005 Jan 31; 33(1):203-8; discussion 259-60. PubMed ID: 15644670
    [Abstract] [Full Text] [Related]

  • 11. Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature.
    Hedna VS, Bidari S, Gubernick D, Ansari S, Satriotomo I, Khan AA, Qureshi AI.
    BMC Neurol; 2014 Nov 18; 14():213. PubMed ID: 25403760
    [Abstract] [Full Text] [Related]

  • 12. Effect of osmotherapy with hypertonic saline on regional cerebral edema following experimental stroke: a study utilizing magnetic resonance imaging.
    Chen CH, Xue R, Zhang J, Li X, Mori S, Bhardwaj A.
    Neurocrit Care; 2007 Nov 18; 7(1):92-100. PubMed ID: 17657661
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
    Chen CH, Toung TJ, Sapirstein A, Bhardwaj A.
    J Cereb Blood Flow Metab; 2006 Jul 18; 26(7):951-8. PubMed ID: 16306935
    [Abstract] [Full Text] [Related]

  • 18. Hypertonic saline attenuates expression of Notch signaling and proinflammatory mediators in activated microglia in experimentally induced cerebral ischemia and hypoxic BV-2 microglia.
    Zeng WX, Han YL, Zhu GF, Huang LQ, Deng YY, Wang QS, Jiang WQ, Wen MY, Han QP, Xie D, Zeng HK.
    BMC Neurosci; 2017 Mar 14; 18(1):32. PubMed ID: 28288585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.